Clinical Trials · NCT04881110
Liraglutide and Peripheral Artery Disease
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Enrollment
- 60
- Start date
- Feb 2021
- Locations
- 1 site, Italy
- Primary endpoint
- Peripheral Transcutaneous Oxygen Pressure